A new study published in JCI Insight suggests that interleukin-7 (IL-7), a key immune-boosting cytokine, may help critically ill COVID-19 patients by reducing life-threatening secondary infections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback